Immunohistopathology and Steroid Profiles Associated With Biochemical Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism
暂无分享,去创建一个
Alessio Burrello | Graeme Eisenhofer | Martin Reincke | Felix Beuschlein | Thomas Knösel | F. Beuschlein | C. Gomez-Sanchez | S. Hahner | I. Castellano | P. Mulatero | J. Lenders | T. Knösel | G. Eisenhofer | T. Nishikawa | M. Reincke | Mirko Peitzsch | L. Rump | G. Kline | Francesco Fallo | Stefanie Hahner | M. Peitzsch | J. Burrello | F. Fallo | A. Burrello | Mitsuhide Naruse | Tracy Ann Williams | Isabella Castellano | T. Kocjan | T. Williams | Lars C. Rump | Paolo Mulatero | Jacques W.M. Lenders | Lucie S. Meyer | Xiao Wang | Eva Sušnik | Jacopo Burrello | Gregory A. Kline | Tomaz Kocjan | Tetsuo Nishikawa | Celso E. Gomez-Sanchez | M. Naruse | E. Susnik | Xiao Wang | Lucie S Meyer | A. Burrello
[1] M. Bäckdahl,et al. Comprehensive Re-Sequencing of Adrenal Aldosterone Producing Lesions Reveal Three Somatic Mutations near the KCNJ5 Potassium Channel Selectivity Filter , 2012, PloS one.
[2] Fiorenzo Gaita,et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. , 2018, The lancet. Diabetes & endocrinology.
[3] Graeme Eisenhofer,et al. Mass Spectrometry-Based Adrenal and Peripheral Venous Steroid Profiling for Subtyping Primary Aldosteronism. , 2016, Clinical chemistry.
[4] R. Kuick,et al. Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands , 2015, Proceedings of the National Academy of Sciences.
[5] S. Ito,et al. Measurement of Peripheral Plasma 18-Oxocortisol Can Discriminate Unilateral Adenoma From Bilateral Diseases in Patients With Primary Aldosteronism , 2015, Hypertension.
[6] S. Tomlins,et al. Aldosterone-Producing Cell Clusters in Normal and Pathological States , 2017, Hormone and Metabolic Research.
[7] D. Nitti,et al. Outcome of surgical treatment of primary aldosteronism , 2015, Langenbeck's Archives of Surgery.
[8] A. Buck,et al. Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma , 2018, Hypertension.
[9] H. Sasano,et al. Development of monoclonal antibodies against human CYP11B1 and CYP11B2 , 2014, Molecular and Cellular Endocrinology.
[10] M. Stowasser,et al. Success of Surgery for Primary Aldosteronism Judged by Residual Autonomous Aldosterone Production , 1998, World Journal of Surgery.
[11] M. Suematsu,et al. Case Report: Nodule Development From Subcapsular Aldosterone-Producing Cell Clusters Causes Hyperaldosteronism. , 2016, The Journal of clinical endocrinology and metabolism.
[12] A. Fassina,et al. Unilateral adrenal hyperplasia: a novel cause of surgically correctable primary hyperaldosteronism. , 2012, Surgery.
[13] C. Gomez-Sanchez,et al. Progress in Primary Aldosteronism: Present Challenges and Perspectives , 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[14] K. Nakagawa,et al. Adrenocortical zonation in humans under normal and pathological conditions. , 2010, The Journal of clinical endocrinology and metabolism.
[15] B. Tops,et al. Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit? , 2014, The Journal of clinical endocrinology and metabolism.
[16] Graeme Eisenhofer,et al. Genotype-Specific Steroid Profiles Associated With Aldosterone-Producing Adenomas , 2016, Hypertension.
[17] C. Gomez-Sanchez,et al. Immunohistochemistry of the adrenal in primary aldosteronism , 2016, Current opinion in endocrinology, diabetes, and obesity.
[18] M. Oya,et al. Immunohistochemistry of aldosterone synthase leads the way to the pathogenesis of primary aldosteronism , 2017, Molecular and Cellular Endocrinology.
[19] Saskia,et al. Targeting CXCR 4 ( CXC Chemokine Receptor Type 4 ) for Molecular Imaging of Aldosterone-Producing Adenoma , 2022 .
[20] F. Nwariaku,et al. Contralateral adrenal abnormalities in Conn's syndrome. , 2016, The Journal of surgical research.
[21] Pierre-François Plouin,et al. Adrenal Cortex Remodeling and Functional Zona Glomerulosa Hyperplasia in Primary Aldosteronism , 2010, Hypertension.
[22] M. Novello,et al. Long-term renal outcomes in patients with primary aldosteronism. , 2006, JAMA.
[23] W. Young,et al. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. , 2016, The Journal of clinical endocrinology and metabolism.
[24] W. Young,et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. , 2017, The lancet. Diabetes & endocrinology.
[25] W. Young,et al. A Novel CYP11B2-Specific Imaging Agent for Detection of Unilateral Subtypes of Primary Aldosteronism. , 2016, The Journal of clinical endocrinology and metabolism.
[26] C. Gomez-Sanchez,et al. Disordered CYP11B2 Expression in Primary Aldosteronism , 2017, Hormone and Metabolic Research.
[27] M. Suematsu,et al. Disorganized Steroidogenesis in Adrenocortical Carcinoma, a Case Study , 2017, Endocrine Pathology.
[28] W. Young,et al. Role for adrenal venous sampling in primary aldosteronism. , 2004, Surgery.
[29] Jeroen J. Bax,et al. 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Blood pressure.
[30] T. Strom,et al. Genetic Spectrum and Clinical Correlates of Somatic Mutations in Aldosterone-Producing Adenoma , 2014, Hypertension.
[31] S. Tomlins,et al. Histopathological Classification of Cross-Sectional Image–Negative Hyperaldosteronism , 2016, The Journal of clinical endocrinology and metabolism.
[32] G. Johannsson,et al. Systematic review of surgery and outcomes in patients with primary aldosteronism , 2015, The British journal of surgery.
[33] Katsutoshi Takahashi,et al. Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009. , 2011, Endocrine journal.
[34] Piotr Ponikowski,et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, European heart journal.
[35] F. Veglio,et al. Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. , 2013, The Journal of clinical endocrinology and metabolism.
[36] Morris J. Brown,et al. Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas. , 2012, The Journal of clinical endocrinology and metabolism.
[37] D. Schteingart. Adrenal Cortex Remodeling and Functional Zona Glomerulosa Hyperplasia in Primary Aldosteronism , 2011 .